Vitamin D retesting by general practitioners: a factor and cost analysis.
Helena ScullyEamon LairdMartin HealyVivion CrowleyJames Bernard WalshKevin McCarrollPublished in: Clinical chemistry and laboratory medicine (2021)
One in four patients were retested and this varied by age, gender and patient location. Over 10% of retests were inappropriately early (<3 months), a third too frequent and over half were in replete individuals incurring significant costs. Clear guidance for GPs on minimum retesting intervals is needed, as well as laboratory ordering systems to limit requests using pre-defined criteria.